ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 674182 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 674182; 2) Community: the network communities that were significantly associated with the response to NSC 674182; 3) Molecule: the relationships between components within communities and NSC 674182; 4) MDR: the compounds that were significantly associated with the NSC 674182.

NSC Compound Enrichment Correlation
NSC 154948 M-AMSA 0.0297837393005856 0.68162782
NSC 163424 4-Quinazolinamine, 2-[2-(1-pyrrolidinylazo)phenyl]- 0.0297837393005856 0.28008287
NSC 275647 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-8-(methoxyacetyl)-, hydrochloride, (8S-cis)- 0.0297837393005856 0.36431461
NSC 321240 Null 0.0297837393005856 0.081396036
NSC 328410 Camptothecin Derivative 0.0297837393005856 0.56727936
NSC 363813 Platinum, tetrachloro(1,2-cyclohexanediamine-N,N')-, [OC-6-22-(1S-trans)]- 0.0297837393005856 0.31680535
NSC 47468 Null 0.0297837393005856 0.27096035
NSC 603578 Platinum, tetrachloro[dimethylsilylenebis(methanamine)]-, (OC-6-22) 0.0297837393005856 0.44169123
NSC 606497 Camptothecin Derivative 0.0297837393005856 0.74307424
NSC 624657 ANTINEOPLASTIC-624657 0.0297837393005856 -0.087287301
Total:54  Current:33    [First] [Prev] [Next] [Last]